Esketamine hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for esketamine hydrochloride and what is the scope of patent protection?
Esketamine hydrochloride
is the generic ingredient in one branded drug marketed by Janssen Pharms and is included in one NDA. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.Esketamine hydrochloride has fifty-eight patent family members in twenty-three countries.
One supplier is listed for this compound.
Summary for esketamine hydrochloride
International Patents: | 58 |
US Patents: | 7 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 23 |
Clinical Trials: | 120 |
Patent Applications: | 33 |
What excipients (inactive ingredients) are in esketamine hydrochloride? | esketamine hydrochloride excipients list |
DailyMed Link: | esketamine hydrochloride at DailyMed |
Recent Clinical Trials for esketamine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Beijing Obstetrics and Gynecology Hospital | Phase 4 |
Obstetrics & Gynecology Hospital of Fudan University | Phase 4 |
VA Office of Research and Development | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for esketamine hydrochloride
Paragraph IV (Patent) Challenges for ESKETAMINE HYDROCHLORIDE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
SPRAVATO | Nasal Spray | esketamine hydrochloride | 28 mg | 211243 | 3 | 2023-03-06 |
US Patents and Regulatory Information for esketamine hydrochloride
International Patents for esketamine hydrochloride
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Morocco | 40620 | RÉGIMES POSOLOGIQUES SPÉCIFIQUES AU GÉNOTYPE VAL66MET (SNP RS6265) ET MÉTHODES POUR LE TRAITEMENT DE LA DÉPRESSION (VAL66MET (SNP rs6265) GENOTYPE SPECIFIC DOSING REGIMENS AND METHODS FOR THE TREATMENT OF DEPRESSION) | ⤷ Try a Trial |
China | 107208133 | 用于治疗抑郁症的Val66Met (SNPrs6265)基因型特异性给药方案和方法 (Val66met (snp rs6265) genotype specific dosing regimens and methods for the treatment of depression) | ⤷ Try a Trial |
Chile | 2018000652 | ⤷ Try a Trial | |
Singapore | 11201507347Q | PHARMACEUTICAL COMPOSITION OF S-KETAMINE HYDROCHLORIDE | ⤷ Try a Trial |
Costa Rica | 20150481 | COMPOSICIÓN FARMACÉUTICA DE CLORHIDRATO DE S-KETAMINA | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2007111880 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |